sulfasalazine has been researched along with pentoxifylline in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Arimura, K; Higuchi, I; Izumo, S; Kawabata, M; Kubota, H; Maruyama, Y; Nakagawa, M; Nakahara, K; Osame, M | 1 |
| Kaklamani, VG; Kaklamanis, PG | 1 |
| Fukuya, H; Hisamatsu, T; Kishikawa, H; Matsuoka, K; Mizuno, Y; Nishida, J | 1 |
| Böcker, U; Singer, MV; Wenz, F; Zimmerer, T | 1 |
| Abdel Hay, R; Al Gendy, N; el-Darouti, M; el-Tawdy, A; Fawzy, M; Gammaz, H; Leheta, T; Marzouk, S | 1 |
| Abdel-Halim, M; Azzam, O; Bassiouny, DA; el-Darouti, M; el-Hadidi, H; el-Hanafy, G; el-Mofty, M; el-Ramly, A; Fawzy, M; Rasheed, H; Zaki, NS | 1 |
| Frew, JW; Martin, LK; Murrell, DF | 1 |
| Abdel Hay, RM; El Hawary, MS; El-Darouti, MA; Fawzy, MM; Hegazy, RA; Rashed, LA; Tawdy, AM | 1 |
3 review(s) available for sulfasalazine and pentoxifylline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Medical prevention and treatment of acute and chronic radiation induced enteritis--is there any proven therapy? a short review.
Topics: Abdominal Neoplasms; Acute Disease; Chronic Disease; Combined Modality Therapy; Controlled Clinical Trials as Topic; Diarrhea; Double-Blind Method; Enteritis; Humans; Intestinal Mucosa; Loperamide; Mesalamine; Octreotide; Parenteral Nutrition, Home; Pelvic Neoplasms; Pentoxifylline; Probiotics; Radiation Injuries; Sulfasalazine; Tocopherols | 2008 |
Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Dapsone; Dermatologic Agents; Epidermal Growth Factor; Evidence-Based Medicine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Medicine, Chinese Traditional; Mycophenolic Acid; Pemphigus; Pentoxifylline; Plasmapheresis; Randomized Controlled Trials as Topic; Sulfasalazine; Tacrolimus | 2011 |
3 trial(s) available for sulfasalazine and pentoxifylline
| Article | Year |
|---|---|
Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antiviral Agents; Ascorbic Acid; Azathioprine; Danazol; Erythromycin; Estrogen Antagonists; Female; Fosfomycin; Glycerol; Human T-lymphotropic virus 1; Humans; Hydrocortisone; Immunoglobulins, Intravenous; Immunosuppressive Agents; Injections, Intramuscular; Injections, Intravenous; Injections, Spinal; Interferon-gamma; Leukapheresis; Male; Methylprednisolone; Middle Aged; Paraparesis, Tropical Spastic; Pentoxifylline; Plasmapheresis; Propiophenones; Respiratory Therapy; Ribonucleosides; Sulfasalazine; Thyrotropin-Releasing Hormone; Vasodilator Agents | 1996 |
Sulfasalazine and pentoxifylline in psoriasis: a possible safe alternative.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pentoxifylline; Phosphodiesterase Inhibitors; Psoriasis; Severity of Illness Index; Statistics, Nonparametric; Sulfasalazine; Treatment Outcome; Young Adult | 2011 |
Study of T helper 1 and T helper 2 responses in pemphigus vulgaris patients receiving interferon alpha 2a injections in addition to a standard protocol therapy: a randomized controlled trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclophosphamide; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Interferon-gamma; Interleukin-4; Male; Middle Aged; Pemphigus; Pentoxifylline; Phosphodiesterase Inhibitors; Recombinant Proteins; Sulfasalazine; Th1 Cells; Th2 Cells | 2015 |
7 other study(ies) available for sulfasalazine and pentoxifylline
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Treatment of Behçet's disease--an update.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Chlorambucil; Colchicine; Cyclophosphamide; Cyclosporine; Dapsone; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferons; Levamisole; Male; Methotrexate; Pentoxifylline; Recombinant Proteins; Recurrence; Sulfasalazine; Thalidomide | 2001 |
Combination therapy including pentoxifylline for entero-Behçet's disease.
Topics: Adult; Aged; Anti-Inflammatory Agents; Behcet Syndrome; Drug Therapy, Combination; Female; Humans; Intestinal Diseases; Middle Aged; Pentoxifylline; Phosphodiesterase Inhibitors; Prednisolone; Sulfasalazine; Treatment Outcome | 2001 |
The use of sulfasalazine and pentoxifylline (low-cost antitumour necrosis factor drugs) as adjuvant therapy for the treatment of pemphigus vulgaris: a comparative study.
Topics: Adult; Aged; Biomarkers; Case-Control Studies; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Cyclophosphamide; Double-Blind Method; Drug Therapy, Combination; Egypt; Female; Humans; Male; Middle Aged; Pemphigus; Pentoxifylline; Phosphodiesterase Inhibitors; Steroids; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2009 |